Calcium and Reduced Body Weight

Doses used in studies

g/day: 0.16–1.5 (median 0.83, IQR 0.16–1.5) — 1 study

Safety in these studies

Overall tolerabilityNo significant difference
Only five studies assessed or reported adverse events. Low-certainty evidence suggests a low frequency of adverse events, with no clear difference between intervention and control groups.
from: Calcium supplementation for people with overweight or obesity.

1 of 1 paper

Calcium supplementation for people with overweight or obesity.

2024-05-09
Meta-Analysis · n = 1,873
The Cochrane database of systematic reviews 2024(5)
- Gabriela Cormick
- Agustín Ciapponi
- Janetta Harbron
- Surya M Perez
- Paula Vazquez
- Julie Rivo
- Maria-Inti Metzendorf
- Fernando Althabe
- José M Belizán

PubMed: 38721870
DOI: 10.1002/14651858.cd012268.pub2

4 Insights on

Reduced Body Weight

High evidence
Clinical

Low-certainty evidence suggests that calcium supplementation compared to placebo or control may result in little to no difference in body weight (mean difference (MD) -0.15 kg, 95% CI -0.55 to 0.24; P = 0.45, I² = 46%; 17 studies, 1317 participants; low-certainty evidence).

Effect: Neutral
Effect size: Small
Significant: No
Dose: 0.162 g/day to 1.5 g/day